2025 Annual Meeting | Industry Therapeutic Update form Eli Lilly and Company: AD in 3D An immersive tour of Alzheimer’s disease and modifiable risk factors
Date
Monday 04/07/25
Time
06:00 PM - 08:00 PM PDT
Add To Calendar
Location
Marriott Marquis | Marriott Grand 3/4/6
Session Format
This program will be presented in-person only
On Demand
This program is not expected to be available in the meeting's On Demand product.
Event Type
Industry Therapeutic Update
Topic(s)
General Neurology, Aging, Dementia, and Behavioral Neurology
Learning Objectives
Join us for an engaging evening dedicated to exploring Alzheimer’s disease (AD) through expert insights and an immersive experience. Enjoy dinner while hearing from a leading specialist on the AD continuum and how holistic health strategies can support cognitive wellness. Participate in an interactive visualization of the development of AD neuropathology, which can begin years prior to the development of symptoms and continues to build through the later stages of the AD continuum. Discover how management of modifiable risk factors can help change the course of care, and how you, as a provider, hold your patients’ future in your hands. This event offers a unique opportunity to deepen your understanding of AD, its impact, and potential approaches for reducing risk.
CME Available
No CME available
Program Materials
Program Evaluations
Event Timeline
06:00 PM - 08:00 PM PDT
Speaker
Industry Therapeutic Update form Eli Lilly and Company: AD in 3D An immersive tour of Alzheimer’s disease and modifiable risk factors